LGND up +3.79% percent right now. $LGND High is at 57.88

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 12:53 PM

LGND up +3.79% percent right now. $LGND High is at 57.88 and the Low 55.60 with current volume of 171,280.

Recent News posted below.

LGND Ligand Pharmaceuticals Inc Recent Headline News

Shares of LGND Up 13.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - 2 hrs 30 mins ago
SmarTrend identified an Uptrend for Ligand Pharmaceuticals (NASDAQ:LGND) on October 17th, 2014 at $48.85. In approximately 4 weeks, Ligand Pharmaceuticals has returned 13.91% as of today's recent price of $55.64.
LGND: 58.05 (+2.37)

Merck presents data from its investigational HCV combo
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 8:37AM CST

JNJ: 108.87 (+0.05), GILD: 108.64 (+1.62), ACHN: 13.16 (+0.31), CNAT: 7.08 (+0.02), MRK: 59.55 (+0.74), LGND: 58.05 (+2.37), RGLS: 20.38 (-0.53), ABBV: 63.99 (+0.20), BMY: 58.92 (+0.11), ENTA: 43.43 (-0.71)

Gilead presents data from three HCV drug combo studies
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 8:05AM CST

JNJ: 108.87 (+0.05), GILD: 108.64 (+1.62), ACHN: 13.16 (+0.31), CNAT: 7.08 (+0.02), LGND: 58.05 (+2.37), RGLS: 20.38 (-0.53), ABBV: 63.99 (+0.20), BMY: 58.92 (+0.11), ENTA: 43.43 (-0.71)

Post Earnings Update: Ligand Pharmaceuticals Has Sunk 0.5% Lower in Past 2 Weeks (LGND)
Comtex SmarTrend(R) - Mon Nov 10, 11:52AM CST
When Ligand Pharmaceuticals (NASDAQ:LGND) reported earnings 14 days ago on October 27th, 2014, analysts, on average, expected the company to report earnings of $0.33 on sales of $14.9 million. The company actually reported EPS of $0.06 on sales of $15.0 million, missing EPS estimates by $0.27 and matching revenue estimates. Shares of Ligand Pharmaceuticals have slipped from $54.23 to $53.94, representing a loss of 0.5%, since the company reported earnings 14 days ago.
LGND: 58.05 (+2.37)

Merck triple therapy HCV candidate fails as a four-week regimen
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 6:49AM CST

JNJ: 108.87 (+0.05), GILD: 108.64 (+1.62), CNAT: 7.08 (+0.02), MRK: 59.55 (+0.74), LGND: 58.05 (+2.37), RGLS: 20.38 (-0.53), ABBV: 63.99 (+0.20), BMY: 58.92 (+0.11), ENTA: 43.43 (-0.71)

Bristol-Myers presents data on HCV Trio regimen
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 5:04PM CST

JNJ: 108.87 (+0.05), GILD: 108.64 (+1.62), CNAT: 7.08 (+0.02), MRK: 59.55 (+0.74), LGND: 58.05 (+2.37), RGLS: 20.38 (-0.53), ABBV: 63.99 (+0.20), BMY: 58.92 (+0.11), ENTA: 43.43 (-0.71)

Bristol-Myers presents data on shorter regimen HCV drug combo
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:37PM CST

JNJ: 108.87 (+0.05), GILD: 108.64 (+1.62), CNAT: 7.08 (+0.02), MRK: 59.55 (+0.74), LGND: 58.05 (+2.37), RGLS: 20.38 (-0.53), ABBV: 63.99 (+0.20), BMY: 58.92 (+0.11), ENTA: 43.43 (-0.71)

Achillion presents HCV data at The Liver Meeting
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:06PM CST

JNJ: 108.87 (+0.05), GILD: 108.66 (+1.64), ACHN: 13.16 (+0.31), CNAT: 7.08 (+0.02), MRK: 59.55 (+0.74), LGND: 58.05 (+2.37), RGLS: 20.38 (-0.53), ABBV: 63.99 (+0.20), BMY: 58.92 (+0.11), ENTA: 43.43 (-0.71)

Ligand Pharmaceuticals Shares Up 12.9% Since SmarTrend's Buy Recommendation (LGND)
Comtex SmarTrend(R) - Mon Nov 03, 10:02AM CST
SmarTrend identified an Uptrend for Ligand Pharmaceuticals (NASDAQ:LGND) on October 17th, 2014 at $48.85. In approximately 2 weeks, Ligand Pharmaceuticals has returned 12.89% as of today's recent price of $55.14.
LGND: 58.05 (+2.37)

Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 1:00PM CDT
Ligand Pharmaceuticals Incorporated (LGND) reported higher third-quarter earnings of 19 cents per share but fell short of the Zacks Consensus Estimate by 2 cents.
BIIB: 326.16 (-1.71), LGND: 58.05 (+2.37), AMGN: 163.23 (+0.14), GSK: 45.80 (+0.64)

Ligand Pharmaceuticals Has Rich A Valuation Now But Is Undervalued For Long Term Success
Chris Katje - at Seeking Alpha - Wed Oct 29, 10:34AM CDT

PFE: 30.21 (+0.01), AZN: 74.26 (+1.05), LGND: 58.05 (+2.37), AMGN: 163.23 (+0.14), GSK: 45.80 (+0.64)

Update: Ligand Posts Consecutive Earnings Beat
Trevor Lowenthal - at Seeking Alpha - Tue Oct 28, 3:21PM CDT

LGND: 58.05 (+2.37)

Ligand Pharmaceuticals' (LGND) CEO Steve Holmes on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Oct 27, 1:56PM CDT

LGND: 58.05 (+2.37)

Ligand Pharmaceuticals reaffirms full year 2014 guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 8:31AM CDT

LGND: 58.05 (+2.37)

Ligand beats Street 3Q forecasts
Automated Insights - Mon Oct 27, 7:16AM CDT
LA JOLLA, Calif. (AP) _ Ligand Pharmaceuticals Inc. (LGND) on Monday reported third-quarter net income of $1.3 million.
LGND: 58.05 (+2.37)

Ligand Pharmaceuticals beats by $0.05, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 7:07AM CDT

LGND: 58.05 (+2.37)

Ligand Reports Third Quarter 2014 Financial Results
Business Wire - Mon Oct 27, 7:01AM CDT
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today reported financial results for the three and nine months ended September 30, 2014, and provided an operating forecast and program updates.
LGND: 58.05 (+2.37)

Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Oct 26, 4:30PM CDT

ROP: 157.25 (-1.28), SIR: 24.19 (-0.05), VNDA: 12.80 (+0.64), STX: 61.63 (-0.14), NMM: 13.62 (-0.02), LGND: 58.05 (+2.37), PDS: 7.90 (+0.14), TREX: 43.98 (-0.03), EXAS: 22.61 (+0.01), AWI: 49.18 (+0.01), EDR: 11.55 (-0.07), HUN: 25.02 (+0.09), TEN: 53.21 (-0.23), AGN: 195.91 (+0.67), ONB: 14.86 (-0.05), STNG: 8.77 (+0.13), MRK: 59.55 (+0.74), BEN: 56.83 (+0.26)

Will Pfizer (PFE) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 4:20PM CDT
Pfizer (PFE) is scheduled to report third-quarter 2014 results before the opening bell on Oct 28.
VRTX: 117.47 (+0.53), PFE: 30.21 (+0.01), LGND: 58.05 (+2.37), TEVA: 58.55 (+0.51)

Will Merck (MRK) Pull a Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 4:10PM CDT
Merck & Co. Inc. (MRK) is scheduled to report third-quarter 2014 results before the opening bell on Oct 27.
MRK: 59.55 (+0.74), LGND: 58.05 (+2.37), TEVA: 58.55 (+0.51)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ohio's Visionary Leadership Honored with Prestigious Award

Award for Exceptional Vision Care Leadership Ain't every day you see a politician scooping up awards for making a real difference in folks' lives. Yet here we are, tipping our hats to Ohio's Governor Mike DeWine, who's just been dubbed the honcho with the golden eye for children's vision care in the 12th annual Bonnie Strickland Champion for Children's Vision Award. Hats...

Smithfield's Foreign Lobbying Interests Unveiled Amid Uproar

A Behind-the-Scenes Drama Over Lobbying Disclosure Something's fishy beneath the surface of Smithfield Foods' recent lobbying debacle. The Center for Responsible Food Business (CRFB) has turned the spotlight on some shady practices, and folks, it ain't pretty. Smithfield's lobbyists had been ducking disclosure rules apparently meant to keep track of foreign influence. Who...

XTrend Speed Extends AFA Sponsorship: Strategic Moves

The Ongoing Alliance Between Finance and Football Well, color me intrigued. XTrend Speed's got their foot in two worlds—a top trading platform and now four years deep into supporting the Argentine Football Association. What's it all about? Primarily, this isn't merely about splashing logos across football kits. It's about syncing prestige, global reach, and excellence....

Aurra Markets Wins 'Most Transparent Broker' Award 2026

Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...

Long Island's JCC Boosted by Manes Family Legacy

Unpacking a Monumental Gift to Long Island's Jewish Community Right out of the gate, this is a big one for the folks over at the Mid Island Y JCC in Plainview, Long Island. They've just hit the jackpot with a historic naming gift, transforming the place into the Manes JCC. Now, why does this matter to anyone keeping tabs on the nonprofit world? Because gifts like these...

AWOL Vision's LuxVision: Pushing Home Cinema Limits

AWOL Vision Leaps into the Future at IFA 2026 You'll never look at home entertainment the same way. AWOL Vision's grand entrance at IFA 2026 in Berlin isn't just about a shiny new gadget; it's a full-blown mission to redefine what your living room can do. With its debut of the LuxVision projector, they're not just holding a torch—they're carrying a flamethrower into the...

Holland America Evolution: Revamping Luxury at Sea

Setting Sail on a Fresh Wave of Luxury It's a whole new world aboard the Oosterdam, folks. Holland America's making waves with the debut of a reimagined Ocean Bar that promises to inject a healthy dose of glamour back into cruising. Forget the stuffy maritime tales of yesteryear; this isn't just a facelift—it's a full-blown Renaissance at sea. A nod to the golden age of...

Catholic Colleges Excel in AI Readiness, Study Shows

Faith and Tech: An Unexpected Alliance? Alright, here's something that'll make you sit up: Catholic college grads are not just busy sipping their morning coffee while they muse over moral philosophy—they're out there on the front lines of artificial intelligence, better prepared and more engaged than their peers from secular schools. According to the latest Holistic...

4Roots Picks MSG for IT & Cybersecurity Support

Tech-Boost for a Community Farm Vision Seems like everyone's buzzing about sustainability these days, and why not? It's the way forward. Take 4Roots and their Farm Campus initiative in Orlando. They've hooked up with Managed Services Group (MSG) to bolster their tech backbone, raising the stakes for their mission to shake up the food system. It's a no-nonsense...

University of Phoenix Boosts Networking Strategies

Building Networks: A Key to Professional Growth Listen up, because everyone and their dog is gabbing about mentorship and networking these days—and for good reason. The University of Phoenix is cracking this nut open with their latest webinar, "Build the Network That Advances Your Career: Mentors, Peers & Community," happening on September 17th. They're not just...